# Phase 178 Local Completion Evidence

## 178.10.1.3 Published Co-Scientist case studies

`@nous/autoresearch-core` includes a source-pinned regression harness for the
published Co-Scientist biomedical validations:

- AML drug repurposing recapitulates the disclosed KIRA6 / IRE1α proposal and
  requires a multi-cell-line dose-response viability plan.
- Liver-fibrosis target discovery requires a druggable epigenetic-modifier,
  approved-drug repurposing proposal and a human-hepatic-organoid experiment
  measuring myofibroblast activity and toxicity.
- The AMR case recapitulates the cf-PICI / diverse-phage-tail host-range
  mechanism and requires a discriminating transfer experiment spanning _E. coli_
  and _K. pneumoniae_.

The executable suite runs each candidate set through the Oshun Generation,
Reflection, Elo Ranking, Evolution, Proximity, and Meta-review loop. Acceptance
requires the disclosed proposal to rank first, complete finding and experiment
criteria, and a monotone best-score curve. Reports include the paper URL,
revision/section pin, and the explicit epistemic status
`retrospective-recapitulation; not independent wet-lab validation`.

Authoritative source: Gottweis et al., “Towards an AI co-scientist,”
<https://arxiv.org/abs/2502.18864>.

Verification commands:

```bash
pnpm nx run nous-autoresearch-core:lint
pnpm nx run nous-autoresearch-core:test
pnpm nx run nous-autoresearch-core:validate-case-studies
```
